Digital to Biological Converter

Digital to Biological Converter
The speed of scientific advancement in genetics and the use of computers in biochemistry is astounding. Scientists mapped the human genome in 2001. In May of 2018, Synthetic Genomics announced that they had created a working Digital to Biological Converter (DBC). The DBC turns digitized DNA code into synthetic biological material such as proteins. The process is called “Gibson Assembly” and can produce small pieces of DNA code called oligonucleotides and stitch the pieces together into DNA strands.

The exciting part of this new technology is that it could allow doctors to personalize medications to the individual needs of patients. Oncologists could create a medicine specifically targeted to the patient’s tumor. It has the potential to create vaccines to fight an epidemic quickly. The prototype machine is too large and too inefficient to be practical, but Synthetic Genomics hopes to have it available to medical researchers in three to five years.

Many of the health problems we have today whether genetic or otherwise have been caused by what we have done to ourselves and our environment with various chemicals and carcinogens. Some might say that we are “playing God” by creating synthetic genetic material. But if we have a way to correct the damage that our ancestors and we have done and relieve pain and suffering, we should certainly do it. The complexity of the Digital to Biological Converter and the material that it produces tells us more of God’s wisdom in the original construction of life.
–John N. Clayton © 2018

Reference: Wall Street Journal. July 14-15, 2018, page B4